The CDC estimates that 37 million people in the US are living with Chronic Kidney Disease and as many as nine out of 10 adults with the disease don’t even know they have it. Black and Hispanic populations are disproportionately impacted by CKD and those with CKD are more likely to face severe illness from COVID-19. All this adds a sense of urgency to the work of furthering
prevention and treatment options for the millions suffering at the hands of this deadly disease.

While leading researchers have identified several areas where additional exploration will advance our ability to prevent and treat CKD, actually delivering these therapies to patients cannot come soon enough. What is the status of federal funding in this area and how should these dollars be allocated? What can policymakers do to address this costly, challenging illness? And what preventative measures, disease management improvements, and life-saving treatments are on the horizon?

The Hill will gather policymakers, physicians, and patient advocates for a conversation on the fight against Chronic Kidney Disease and how we can improve the diagnosis, prognosis, and treatment options for CKD.